On our screens:Stocks that buy back more than they dilute
The financials
Medtronic by the numbers
Medtronic (MDT) reported revenue of $9.76B in Q1 2027 (quarter ended Jul 31, 2026), up 14% from the same quarter a year earlier. That came with a gross margin of 65% and net income of $1.47B (15% of revenue). For the full year FY2026, revenue was $36.4B (+8.4% year on year) and net income $4.80B. Its largest region in Q4 2026 (quarter ended Apr 24, 2026) was Total Other Countries Excluding Ireland at $9.77B, 100% of the disclosed total, well ahead of Ireland at 0.4%.
| Income statement | Q1 2027 | Q1 2026 | Change |
|---|---|---|---|
| Revenue | $9.76B | $8.58B | +14% |
| Gross profit | $6.34B | $5.58B | +14% |
| Operating income | $1.76B | $1.45B | +22% |
| Net income | $1.47B | $1.04B | +41% |
| Diluted EPS | $1.14 | $0.81 | +41% |
| Geographic | Revenue | Share |
|---|---|---|
| Total Other Countries Excluding Ireland | $9.77B | 100% |
| Ireland | $39M | 0.4% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q4 2026Total $9.81B (+8.8%)
Ireland grew +34% year on yearTotal Other Countries Excluding Ireland +9.8% year on year
Segment Latestquarter on quarteryear on year
- Total Other Countries Excluding Ireland$9.77B$9.77BQoQ +8.8%year on year +9.8%+8.8%+9.8%
- Ireland$39.0M$39.0MQoQ +8.3%year on year +34%+8.3%+34%
Medical Devices
The closest names by size in the same industry